Search miRCancer Database

Search by miRNA name:      Or     And       cancer name:        

Example: mir-145, hsa-mir-21, let-7			 Example: breast cancer, lung

Search result for miRNA = 'hsa-mir-217' Or cancer = '' Total: 31 relations found.

mirId Family/Cluster Cancer Profile PubMed Article
hsa-mir-217 acute myeloid leukemia down MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS.
hsa-mir-217 breast cancer up MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1.
hsa-mir-217 cervical cancer down MicroRNA-217 functions as a tumor suppressor in cervical cancer cells through targeting Rho-associated protein kinase 1.
hsa-mir-217 colorectal cancer down miR-217 regulates tumor growth and apoptosis by targeting the MAPK signaling pathway in colorectal cancer.
hsa-mir-217 gastric cancer down microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.
hsa-mir-217 gastric cancer down The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5.
hsa-mir-217 gastric cancer down MicroRNA-217 suppressed epithelial-to-mesenchymal transition in gastric cancer metastasis through targeting PTPN14.
hsa-mir-217 gastric cancer down HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression.
hsa-mir-217 gastric cancer down Long non-coding RNA Hotair promotes gastric cancer progression via miR-217-GPC5 axis.
hsa-mir-217 glioblastoma up MiR-217 promoted the proliferation and invasion of glioblastoma by repressing YWHAG.
hsa-mir-217 glioma down MicroRNA-217 inhibits cell proliferation and invasion by targeting Runx2 in human glioma.
hsa-mir-217 glioma down TTBK2 circular RNA promotes glioma malignancy by regulating miR-217/HNF1?/Derlin-1 pathway.
hsa-mir-217 hepatocellular carcinoma up MiR-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
hsa-mir-217 hepatocellular carcinoma down miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3.
hsa-mir-217 hepatocellular carcinoma down Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
hsa-mir-217 hepatocellular carcinoma down miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma.
hsa-mir-217 hepatocellular carcinoma up miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma.
hsa-mir-217 laryngeal cancer down miR-217 inhibits laryngeal cancer metastasis by repressing AEG-1 and PD-L1 expression.
hsa-mir-217 liver cancer down HOTAIR contributes to the growth of liver cancer via targeting miR-217.
hsa-mir-217 lung cancer down MicroRNA-217 functions as a tumour suppressor gene and correlates with cell resistance to cisplatin in lung cancer.
hsa-mir-217 non-small cell lung cancer down MicroRNA-217 alleviates development of non-small cell lung cancer by inhibiting AKT3 via PI3K pathway.
hsa-mir-217 osteosarcoma down MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma.
hsa-mir-217 osteosarcoma down The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma.
hsa-mir-217 osteosarcoma down Loss of miR-217 promotes osteosarcoma cell proliferation through targeting SETD8.
hsa-mir-217 pancreatic adenocarcinoma down MicroRNA-217 inhibits cell proliferation, invasion and migration by targeting Tpd52l2 in human pancreatic adenocarcinoma.
hsa-mir-217 pancreatic ductal adenocarcinoma down The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
hsa-mir-217 pancreatic ductal adenocarcinoma down MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
hsa-mir-217 pancreatic ductal adenocarcinoma down MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.
hsa-mir-217 pancreatic ductal adenocarcinoma down Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma.
hsa-mir-217 renal cell carcinoma down LncRNA HOTAIR regulates HIF-1?/AXL signaling through inhibition of miR-217 in renal cell carcinoma.
hsa-mir-217 thyroid cancer down miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.